share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

諾瓦瓦克斯醫藥 | 4:持股變動聲明-高管 Draghia-Akli Ruxandra
美股SEC公告 ·  2024/11/14 05:15

牛牛AI助理已提取核心訊息

Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.
根據最近的文件,諾瓦克斯公司(NVAX)報告了與Ruxandra Draghia-Akli有關的一筆交易,該人具有與發行人的第16節關係。這筆交易發生在2024年11月11日。然而,文件沒有披露具體細節,如行動類型、狀態、股份數量、股份性質、交易價格或涉及的股份總價值。交易後Draghia-Akli持有的股份數量也未提供。投資者被建議等待進一步細節,以全面評估這筆交易對他們投資決策的影響。
根據最近的文件,諾瓦克斯公司(NVAX)報告了與Ruxandra Draghia-Akli有關的一筆交易,該人具有與發行人的第16節關係。這筆交易發生在2024年11月11日。然而,文件沒有披露具體細節,如行動類型、狀態、股份數量、股份性質、交易價格或涉及的股份總價值。交易後Draghia-Akli持有的股份數量也未提供。投資者被建議等待進一步細節,以全面評估這筆交易對他們投資決策的影響。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。